Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Sales and Supply Contract / 2025-04-30 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Acquisition of Treasury Stock / 2026-01-29 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Shortage Scenario · AI-Driven Portfolio Shift · Valuation Re-rating / 2025-11-24 RESEARCH
  • [Research] SK hynix (000660 / SKHY) – Daishin | Supply Constraints · Multi-Year LTA · Shareholder Returns / 2026-04-24 RESEARCH
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2025-01-23 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2024-11-18 Disclosures
  • [Disclosure] SK Square (402340) – (Correction) Decision on Issuance of Depositary Receipts / 2026-07-10 Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Decision on Rights Offering (Correction Disclosure) / 2026-02-13

Posted on February 13, 2026August 11, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)

💡 3-Second Summary

SK hynix’s U.S. subsidiary (SK hynix NAND Product Solutions Corp.) has issued a correction disclosure regarding its USD 10B (KRW 14.428T) rights offering, updating key schedule dates including the subscription start date and record date due to a change in the contract execution date.

📊 [Key Disclosure Content & Key Figures Summary]

  • Correction Details
    • Correction Date: 2026-02-13 (Initial Filing Date: 2026-01-28)
    • Reason for Correction: Revisions to major schedule dates following changes in the contract execution date
    • Key Modifications:
      • Record Date for New Share Allocation: Revised from 2030-01-28 to 2030-03-01
      • Subscription Start Date for Existing Shareholders: Revised from 2026-01-28 to 2026-03-01
      • Subscription End Date, Payment Date, and Certificate Delivery Date: Revised from 2030-01-28 to 2030-03-01
  • Target Subsidiary Information
    • Company Name: SK hynix NAND Product Solutions Corp. (Representatives: Xin Guo, Jinsoo Kang)
    • Main Business: Semiconductor Sales and R&D
    • Subsidiary Total Assets: KRW 6,199,002,267,673 (5.2% of parent company’s consolidated total assets of KRW 119,855,208,683,285 as of FY2024 end)
  • Details of Rights Offering
    • Type and Number of New Shares: 10,000,000,000 common shares
    • Par Value Per Share: KRW 1,442.80 (USD 1, converted at 1,442.8 KRW/USD)
    • Total Outstanding Shares Before Rights Offering: 1,693,653,240 common shares
    • Purpose of Funding: Acquisition of securities of another corporation KRW 14,428,000,000,000 (USD 10B)
    • Method of Rights Offering: Shareholder-allocated rights offering (100% to parent company)
  • Issuance Price & Schedule
    • Confirmed Issuance Price: KRW 1,442.80 per common share (USD 1)
    • Subscription Period: Start Date (Contract execution date) 2026-03-01 ~ End Date (Final limit date) 2030-03-01
    • Payment Date / Certificate Delivery Date: 2030-03-01
    • Subsidiary Board Resolution Date: 2026-01-28 (1 Outside Director attended)
    • Exemption from Securities Report: Applicable (100% owned unlisted overseas subsidiary)
  • Other Matters Significant to Investment Decisions
    • Subscription start date reflects contract execution, while the end date represents the final limit date within which capital contributions will proceed based on project progress
    • Actual contribution will be executed by the surviving entity following a merger between the subsidiary and a new U.S. entity scheduled to be incorporated

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Commencement of Adjusted Subscription Schedule and Merger Progress

This amendment defers the subscription start date and payment limit timeline to align with the revised contract execution schedule for the subsidiary’s capital increase. Verifying whether contract execution commences on the adjusted subscription date and tracking the progress of the subsequent merger with the U.S. subsidiary is essential for assessing the execution timeline of SK hynix’s overseas corporate restructuring. Further updates and detailed progress can be monitored through subsequent regulatory filings or future periodic reports (Quarterly, Half-Yearly, or Annual Reports).

📢 Disclaimer & Source Notice

Source: This content was newly structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] SK hynix (000660 / SKHY) – Decision on Acquisition of Shares and Investment Securities of Other Corporation (Correction Disclosure) / 2026-02-13
Next Post: [Disclosure] SK hynix (000660 / SKHY) – Modification of Listing (Retirement of Shares) / 2026-02-13

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-06-25 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Voluntary Disclosure Regarding Sustainability Report / 2026-06-30 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-06-20 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Results of Annual General Meeting of Shareholders / 2026-03-20 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Provisional Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2024-10-23 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Execution of Single Sales or Supply Contract (Correction) / 2026-04-01 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-12-23 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | MLCC Mix · FC-BGA · Glass Substrate / 2025-03-11 RESEARCH
  • [Research] SK hynix (000660 / SKHY) – Daishin Securities | Dual DRAM & NAND Expansion · 2Q24 8Hi HBM3E Ramp · Target Price Raised / 2024-04-26 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | Silicon Capacitor LTA · 800VDC Infrastructure · 2027 Operating Profit 3T / 2026-05-21 Semiconductors
  • [Disclosure] SK Square (402340) – Information on Reference Price for Interim (Quarterly) Ex-Dividend / 2026-05-13 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Setting of Record Date for Shareholders / 2026-08-04 Disclosures
  • [IR] SK hynix (000660 / SKHY) – Q4 2024 Earnings Presentation / 2025-01-23 IR Room
  • [Disclosure] Celltrion (068270) – Execution of Joint R&D and License Agreement for PD-1 x VEGF x IL-2v Tri-functional Fusion Protein / 2025-10-31 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme